Key result
Repeated episodes of dobutamine-induced ischemia caused more severe impairment of ejection fraction and systolic function 45 minutes after the second episode compared to the first (P<0.01).
Why the study?
Do repeated episodes of dobutamine-induced ischemia lead to cumulative myocardial stunning in patients with coronary artery disease?
Observational (n=9)
Do repeated episodes of dobutamine-induced ischemia lead to cumulative myocardial stunning in patients with coronary artery disease?
p-value: p=< 0.01
Repeated episodes of dobutamine-induced ischemia lead to cumulative myocardial stunning, as evidenced by more severe impairment of ejection fraction and regional systolic function after a second ischemic episode.
Should not yet change stress testing protocols; hypothesis-generating for cumulative stunning and needs prospective validation.
Nine patients with coronary artery disease and normal left ventricular (LV) function underwent two episodes of dobutamine-induced ischemia to determine whether repeated episodes of ischemia lead to cumulative stunning. Positron emission tomography (PET) and oxygen 15-labeled H(2)O was used to assess myocardial blood flow (MBF) at baseline, peak stress, and after stress for each ischemic episode. Quantitative echocardiographic assessment of global ejection fraction (EF) and regional systolic function (SF) was performed at rest and regular intervals after dobutamine. SF was assessed for regions subtended by a coronary artery with a >70% diameter stenosis. Both EF and SF were more severely impaired 45 min after the second episode of stress compared with 45 min after the first (both P < 0.01), despite no difference in duration of the two dobutamine infusions or MBF at peak stress (1.72 vs. 1.69). After both episodes of ischemia, when LV function was impaired but subsequently recovered, MBF (1.15 +/- 0.39 and 1.20 +/- 0.43, respectively) was no different to baseline MBF (1.02 +/- 0.35), confirming that repeated episodes of dobutamine-induced ischemia lead to cumulative myocardial stunning.
No takes yet. Share an insight, caveat, or question.
Barnes et al. (2002) conducted an observational in coronary artery disease and normal left ventricular (LV) function (n=9). Repeated episodes of dobutamine-induced ischemia vs. First episode of dobutamine-induced ischemia was evaluated on global ejection fraction (EF) and regional systolic function (SF) impairment (p=< 0.01). Repeated episodes of dobutamine-induced ischemia caused more severe impairment of ejection fraction and systolic function 45 minutes after the second episode compared to the first (P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: